- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 498/06 - Peri-condensed systems
Patent holdings for IPC class C07D 498/06
Total number of patents in this class: 312
10-year publication summary
|
32
|
20
|
26
|
14
|
19
|
13
|
21
|
18
|
24
|
7
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4872 |
20 |
| Incyte Holdings Corporation | 652 |
14 |
| Merck Patent GmbH | 5861 |
11 |
| LG Chem, Ltd. | 17581 |
7 |
| Incyte Corporation | 1018 |
7 |
| Samsung Display Co., Ltd. | 34349 |
6 |
| Genentech, Inc. | 3976 |
6 |
| Janssen Pharmaceutica N.V. | 3407 |
5 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 695 |
5 |
| KYORIN Pharmaceutical Co., Ltd. | 169 |
5 |
| Adlai Nortye Biopharma Co., Ltd. | 56 |
5 |
| AstraZeneca AB | 2924 |
4 |
| Glaxosmithkline Intellectual Property Development Limited | 757 |
4 |
| Henkel AG & Co. KGaA | 10513 |
4 |
| CTI Biopharma Corp. | 35 |
4 |
| Rigel Pharmaceuticals, Inc. | 539 |
4 |
| Onkure, Inc. | 26 |
4 |
| AstraZeneca UK Limited | 655 |
3 |
| Daiichi Sankyo Company, Limited | 1859 |
3 |
| King's College London | 532 |
3 |
| Other owners | 188 |